Roberta Losi Guembarovski (Roberta Losi-Guembarovski)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Prostate Cancer

Cell Proliferation

Top Venues

Journal of cancer research and clinical oncology

Journal of clinical laboratory analysis

This page only lists publications with an associated author ORCID identifier.

Publications

Nádia Calvo Martins Okuyama, Fernando Cezar-Dos-Santos, Kleber Paiva Trugilo, Aline Esposito, Roberta Losi Guembarovski, José d'Oliveira Couto-Filho, Maria Angelica Ehara Watanabe, Karen Brajão de Oliveira
CXCL12/CXCR4 axis gene variants contribute to an increased vulnerability to HPV infection and cervical oncogenesis. Journal of cancer research and clinical oncology 148 (4) (2022)
Érica Romão Pereira, Laís Capelasso Lucas Pinheiro, Amanda Letícia Francelino, Carlos Alberto Miqueloto, Alda Fiorina Maria Losi Guembarovski, Karen Brajão de Oliveira, Paulo Emílio Fuganti, Ilce Mara de Syllos Cólus, Roberta Losi Guembarovski
Tissue immunostaining of candidate prognostic proteins in metastatic and non-metastatic prostate cancer. Journal of cancer research and clinical oncology (2022)
Glauco Akelinghton Freire Vitiello, Nathália de Sousa-Pereira, Marla Karine Amarante, Bruna Karina Banin Hirata, Clodoaldo Zago Campos, Karen Brajão de Oliveira, Roberta Losi Guembarovski, Maria Angelica Ehara Watanabe
Germline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort. Journal of cancer research and clinical oncology 146 (6) (2020)
Felipe Campos de Almeida, Bruna Karina Banin Hirata, Carolina Batista Ariza, Roberta Losi Guembarovski, Karen Brajão de Oliveira, Karen Mayumi Suzuki, Alda Losi Guembarovski, Julie Massayo Maeda Oda, Glauco Akelinghton Freire Vitiello, Maria Angelica Ehara Watanabe
HER2 Ile655Val polymorphism is negatively associated with breast cancer susceptibility. Journal of clinical laboratory analysis 32 (6) (2018)